Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of blood cancer
3.2.1.2 Advancements in cancer diagnostic technologies
3.2.1.3 Growing awareness and early screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced diagnostics
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTLE analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Assay kits and reagents
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Blood tests
6.3 Imaging tests
6.4 Biopsy
6.5 Molecular tests
Chapter 7 Market Estimates and Forecast, By Cancer Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Leukemia
7.3 Lymphoma
7.4 Myeloma
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Diagnostic imaging centers
8.5 Cancer research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Alercell, Inc.
10.3 Becton, Dickinson and Company
10.4 Bio-Rad Laboratories, Inc.
10.5 Bio-Techne Corporation
10.6 Danaher Corporation
10.7 F. Hoffmann-La Roche Ltd
10.8 GE HealthCare Technologies Inc.
10.9 HORIBA, Ltd.
10.10 Illumina, Inc.
10.11 Invivoscribe, Inc.
10.12 QIAGEN N.V.
10.13 Sysmex Corporation
10.14 Thermo Fisher Scientific Inc.
